Misplaced Pages

Acefylline

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Acefylline piperazine) Chemical compound Pharmaceutical compound
Acefylline
Skeletal formula of acefylline
Ball-and-stick model of the acefylline molecule
Clinical data
Routes of
administration
Intramuscular, Intravenous
ATC code
Identifiers
IUPAC name
  • (1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.010.447 Edit this at Wikidata
Chemical and physical data
FormulaC9H10N4O4
Molar mass238.203 g·mol
3D model (JSmol)
SMILES
  • O=C2N(c1ncn(c1C(=O)N2C)CC(=O)O)C
InChI
  • InChI=1S/C9H10N4O4/c1-11-7-6(8(16)12(2)9(11)17)13(4-10-7)3-5(14)15/h4H,3H2,1-2H3,(H,14,15)
  • Key:HCYFGRCYSCXKNQ-UHFFFAOYSA-N
  (verify)

Acefylline (INN), also known as 7-theophyllineacetic acid, is a stimulant drug of the xanthine chemical class. It acts as an adenosine receptor antagonist. It is combined with diphenhydramine in the pharmaceutical preparation etanautine to help offset diphenhydramine induced drowsiness.

A silanolmannuronic acid conjugate of acefylline, acefylline methylsilanol mannuronate (INCI; trade name Xantalgosil C) is marketed as a lipolytic phosphodiesterase inhibitor. It is used as an ingredient in cosmeceuticals for the treatment of cellulite and as a skin conditioner.

See also

References

  1. "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 21" (PDF). World Health Organization. Retrieved 29 December 2016.
  2. Zuidema J (1978). "Biofarmaceutische en farmacokinetische aspecten van theofylline en acefylline". Thesis (doctoral)--Universiteit van Amsterdam. Archived from the original on 2016-12-30. Retrieved 2012-09-29. {{cite journal}}: Cite journal requires |journal= (help)
  3. Biosil Technologies (2005). "Xantalgosil C® Datasheet" (PDF). Exsymol S.A.M. Retrieved 2022-01-20.
  4. Winter, Ruth (2009-10-20). A Consumer's Dictionary of Cosmetic Ingredients (7th ed.). Harmony/Rodale. p. 42. ISBN 9780307459862.
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
Glucocorticoids
Anticholinergics/
muscarinic antagonist
Mast cell stabilizers
Xanthines
Eicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthine PDE4 inhibitors
Others/unknown
Combination products
Purine receptor modulators
Receptor
(ligands)
P0 (adenine)
P1
(adenosine)
P2
(nucleotide)
P2X
(ATPTooltip Adenosine triphosphate)
P2Y
Transporter
(blockers)
CNTsTooltip Concentrative nucleoside transporters
ENTsTooltip Equilibrative nucleoside transporters
PMATTooltip Plasma membrane monoamine transporter
Enzyme
(inhibitors)
XOTooltip Xanthine oxidase
Others
Others
See also: Receptor/signaling modulators


Stub icon

This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it.

Categories: